2[1]Bou G, Oliver A, Martrinez J, et al. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain[J]. Antimicrob Agents Chemother, 2000, 44(6): 1556-1561.
3[2]Iregbu K C, Ogunsola F T, Odugbemi T O. Infections caused by Acinetobacter species and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos[J]. West Afr J med, 2002, 21(3): 226-229.
4[3]Scerpella E G, Wanger A R, Armitige L, et al. Nosocomial outbreak caused by 9 multiresistance clone of Acinetobacter baumannii; results of the case control and molecular epidemiologic investigations[J]. Infect Control Hosp Epidemiol, 1995, 16(2): 92-97.
5[5]Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J]. J Antimicrob Chemother, 2003, 51(3): 565-74.
6[6]Gales A C, Tognim M C, Reis A O, et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital[J]. Diagn Microbiol Infect Dis, 2003, 45(1): 77-79.
7[8]Rodriguez-Bano J, Pascual A, Gavez J, et al. Acinetobacter baumannii bacteremia: clinical and prognostic features[J]. Enferm Infect Microbiol Clin, 2003, 21(5): 242-277.
8[5]Bush K,Jscky GA,Medeiros A.A functional classification scheme for β-lactamase and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995,39(6): 1211.
